{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-055992","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.732312+00:00","generated_at":"2026-05-20T01:00:10.285065+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Fennec shareholders approve all proposals at annual meeting, including director elections and equity plan amendment","bullets":["All six director nominees elected; votes for each exceeded 13.2M versus under 1M withheld.","Haskell & White LLP ratified as independent auditor with 19.67M votes for, 69k against.","Advisory say-on-pay approved: 12.11M for, 1.60M against, 456k abstain.","Amendment to 2020 Equity Incentive Plan approved: 12.93M for, 0.78M against, 459k abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-055992","json":"https://secwatch.observer/filing/0001104659-25-055992.json","markdown":"https://secwatch.observer/filing/0001104659-25-055992.md","text":"https://secwatch.observer/filing/0001104659-25-055992.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465925055992/0001104659-25-055992-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465925055992/tm2517069d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:00:10.285065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}